Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas
暂无分享,去创建一个
Iver Petersen | Wilko Weichert | Arne Warth | Albrecht Stenzinger | Benjamin Goeppert | I. Petersen | A. Warth | W. Weichert | A. Stenzinger | P. Schnabel | B. Goeppert | H. Hoffmann | Hans Hoffmann | Philipp A Schnabel | J. Cortis | A. von Brünneck | Ann-Christin von Brünneck | Judith Cortis | Ann-Christin von Brünneck
[1] Jonathan I. Epstein,et al. Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial. , 2011, Urology.
[2] Michael Thomas,et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[4] J. Coindre. Grading of soft tissue sarcomas: review and update. , 2009, Archives of pathology & laboratory medicine.
[5] Yang Xue-ning. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011 .
[6] Lars Egevad,et al. Interobserver reproducibility of modified Gleason score in radical prostatectomy specimens , 2003, Virchows Archiv.
[7] Jeffrey W. Clark,et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. , 2010, The New England journal of medicine.
[8] S. Hauptmann,et al. Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] E. Brambilla,et al. The evolving role of histology in the management of advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Masahiro Tsuboi,et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[11] A. Nicholson,et al. Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis , 2008, European Respiratory Journal.
[12] Akihiko Yoshizawa,et al. A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors , 2010, The American journal of surgical pathology.
[13] D. Wigle,et al. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations , 2010, Expert review of respiratory medicine.
[14] S S Cross,et al. Grading and scoring in histopathology , 1998, Histopathology.
[15] M. Rubin,et al. Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays , 2008, Journal of Cancer Research and Clinical Oncology.
[16] Akihiko Yoshizawa,et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases , 2011, Modern Pathology.
[17] R Y Ball,et al. A study of Gleason score interpretation in different groups of UK pathologists; techniques for improving reproducibility , 2006, Histopathology.
[18] R. Rami-Porta,et al. The New Tumor, Node, and Metastasis Staging System , 2011, Seminars in respiratory and critical care medicine.
[19] S. Moss,et al. A UK‐based investigation of inter‐ and intra‐observer reproducibility of Gleason grading of prostatic biopsies , 2006, Histopathology.
[20] M. D. den Bakker,et al. Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability , 2010, Histopathology.
[21] O. O. Miller. Lung cancer. , 1954, The Journal of the Kentucky State Medical Association.
[22] C. Comin,et al. EU–USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer , 2006, European Respiratory Journal.
[23] Zoe Wainer,et al. Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[24] Lin Huan,et al. Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer , 2010 .
[25] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.